MEDP
Medpace Holdings Inc
Medpace Holdings Inc historical holders
total: 8
Turtle Creek Asset Management Medpace Holdings Inc transactions over time
- Total transactions:
- 4
- New positions:
- 1
- Added:
- 1
- Reduced:
- 2
- Held since:
- 2025 Q2
- Held for:
- 4 quarters
- Latest activity:
- 2026 Q1
Andrew Brenton has been an institutional investor in Medpace Holdings Inc (MEDP) since 2025 Q2. According to 2026 Q1 report, Andrew Brenton holds 135,570 shares with a market value of roughly $65.10M representing 2.44% of their equity portfolio. The fund/company first acquired MEDP in 2025 Q2, initially purchasing 11,000 shares. Since the initial investment, Turtle Creek Asset Management has made 3 more transactions in this position.
Does Andrew Brenton still hold MEDP?
Yes, Andrew Brenton continues to hold Medpace Holdings Inc (MEDP). According to their 2026 Q1 report, they maintain a position of 135,570 shares valued at approximately $65.10M, representing 2.44% of their equity portfolio.
When did Andrew Brenton first invest in MEDP?
Andrew Brenton first invested in Medpace Holdings Inc (MEDP) in 2025 Q2 at the reported quarter-end price of $313.86 per share, acquiring 11,000 shares in their initial purchase.
What is Andrew Brenton's average cost basis for MEDP?
Based on historical transaction data, Andrew Brenton's estimated cost basis for Medpace Holdings Inc (MEDP) is approximately $467.46 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $467.46
- Weighted AVG sell price:
- $525.74
MEDP transactions history by Turtle Creek Asset Management
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
2.44%
|
135,570
|
$480.19
|
$65,099,358
|
+4,741.79% (+132,770)
|
+2.39%
|
|
2025 Q4
|
0.07%
|
2,800
|
$561.65
|
$1,572,620
|
-41.67% (-2,000)
|
-0.03%
|
|
2025 Q3
|
0.07%
|
4,800
|
$514.16
|
$2,467,968
|
-56.36% (-6,200)
|
-0.09%
|
|
2025 Q2
|
0.10%
|
11,000
|
$313.86
|
$3,452,460
|
new
|
+0.1%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.